Kiwi Wealth Investments Limited Partnership’s Vertex Pharmaceuticals VRTX Stock Holding History

Kiwi Wealth Investments Limited Partnership’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-13,697	Closed	-$3.58M	–	241
2022 Q1	$3.58M	Buy	+13,697	New	+$3.25M	0.19%	134
2021 Q3	–	Sell	-27,581	Closed	-$5.56M	–	275
2021 Q2	$5.56M	Buy	27,581 +1,245	+5%	+$260K	0.29%	86
2021 Q1	$5.66M	Buy	26,336 +2,876	+12%	+$632K	0.33%	82
2020 Q4	$5.54M	Buy	23,460 +20,988	+849%	+$4.82M	0.33%	85
2020 Q3	$673K	Hold	2,472	–	–	0.05%	224
2020 Q2	$718K	Sell	2,472 -3,264	-57%	-$885K	0.06%	190
2020 Q1	$1.36M	Hold	5,736	–	–	0.14%	142
2019 Q4	$1.26M	Sell	5,736 -5,224	-48%	-$1.06M	0.09%	162
2019 Q3	$1.86M	Hold	10,960	–	–	0.15%	147
2019 Q2	$2.01M	Buy	+10,960	New	+$1.92M	0.18%	136

Other funds holding VRTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Kiwi Wealth Investments Limited Partnership's VRTX Position: Q2 2022 in Review

Kiwi Wealth Investments Limited Partnership sold out of Vertex Pharmaceuticals (VRTX) in Q2 2022, closing a stake of 13,697 shares — an estimated $3.58M sold.

Kiwi Wealth Investments Limited Partnership first reported a position in VRTX in Q2 2019 and held it in 10 quarters. The position peaked at $5.66M in Q1 2021. 1,107 funds tracked by Wall St. Rank hold VRTX as of Q2 2022.

Kiwi Wealth Investments Limited Partnership reported no remaining Vertex Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
Kiwi Wealth Investments Limited Partnership sold 13,697 Vertex Pharmaceuticals shares in Q2 2022, an estimated $3.58M.
Kiwi Wealth Investments Limited Partnership first reported a position in Vertex Pharmaceuticals in Q2 2019 and held it in 10 quarters.
Kiwi Wealth Investments Limited Partnership's Vertex Pharmaceuticals position peaked at $5.66M in Q1 2021.
1,107 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2022.

Based on Kiwi Wealth Investments Limited Partnership's 13F filing for Q2 2022, filed 12 Aug 2022.